Anxiolytic of Choice in Breastfeeding
Lorazepam or midazolam are the preferred anxiolytics for breastfeeding mothers, with lorazepam being the better choice for ongoing anxiety management and midazolam for acute procedural sedation. These shorter-acting benzodiazepines are safer than diazepam, which has a prolonged active metabolite that transfers significantly into breast milk 1.
Recommended Benzodiazepines During Breastfeeding
First-Line Choices
Lorazepam is among the shorter-acting benzodiazepines explicitly recommended in the 2020 Association of Anaesthetists guideline 1. While the guideline doesn't provide extensive pharmacokinetic details for lorazepam specifically, it is grouped with midazolam and temazepam as preferable alternatives to diazepam due to their shorter duration of action.
Midazolam has extensive first-pass metabolism resulting in low systemic bioavailability after oral doses, meaning blood levels in the infant after breastfeeding are expected to be low 1. Breastfeeding can resume after a single dose as soon as the mother has recovered from the procedure.
Avoid or Use with Extreme Caution
Diazepam should be avoided for ongoing anxiety management. It has an active metabolite (desmethyl-diazepam) with a prolonged half-life and transfers into breast milk at significant levels 1. The guideline states it may only be considered as a one-off dose before a procedure, not for chronic anxiety treatment.
Alternative Non-Benzodiazepine Option
Buspirone represents an excellent alternative for chronic anxiety management in breastfeeding mothers. A 2024 study demonstrated that buspirone was below detection levels (1.5 ng/mL) in all milk samples at doses ranging from 7.5 to 30 mg twice daily 2. The relative infant dose (RID) ranged from only 0.21% to 2.17%, well below the 10% safety threshold, with no adverse effects reported in exposed infants. This makes buspirone particularly attractive as it carries minimal risk of dependence or respiratory depression.
Clinical Decision Algorithm
For acute anxiety or procedural sedation:
- Use midazolam as first choice
- Resume breastfeeding once mother has recovered from sedation
- Single doses pose minimal infant risk
For ongoing anxiety management:
- Prefer lorazepam among benzodiazepines (shorter-acting, safer profile)
- Consider buspirone as first-line to avoid benzodiazepine exposure entirely (RID 0.21-2.17%, no reported adverse effects)
- Avoid diazepam due to long-acting metabolite accumulation
For short-term anxiety relief:
- Benzodiazepines can be administered during breastfeeding according to 2024 consensus recommendations 3
- Use lowest effective dose for shortest duration
- Monitor infant for drowsiness or poor feeding
Important Caveats
Dexmedetomidine should be used with caution as its excretion into breast milk is unknown, despite having a short 2-hour half-life 1.
General monitoring: Regardless of which anxiolytic is chosen, mothers should observe infants for signs of drowsiness, poor feeding, or sedation. If these occur, contact a medical professional immediately.
Consensus support: The 2024 international consensus panel representing eight scientific societies confirmed that anxiety disorders and their pharmacological treatment are not contraindications for breastfeeding 3. The panel specifically endorsed benzodiazepines for short-term anxiety relief during lactation.
The evidence strongly supports that properly selected anxiolytics pose minimal risk to breastfed infants while allowing mothers to receive necessary treatment for anxiety disorders, which if left untreated, pose their own risks to both maternal and infant wellbeing 3.